LEMAITRE VASCULAR INC (LMAT)
Every FINRA and SEC series the site collects for LEMAITRE VASCULAR INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
1.5M
Short interest
settlement 2026-08-31
4.8
Days to cover
-5.5% vs prior
68.8%
Short share of volume
2026-09-17
55
Fails to deliver
settlement 2026-08-27
Thu 5 Nov
Next earnings
estimated; last year 2025-11-06
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in LMAT is 1,521,649 shares, up 75,360 shares over the last month. Over the last 48 readings it ranged from 756,312 shares (15 November 2024) to 1,609,925 shares (14 August 2026). At the reported average volume of 318K shares a day that is 4.8 days to cover.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/lmat" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 1,521,649 | -5.5% | 318,109 | 4.78 |
| 2026-08-14 | 1,609,925 | +11.3% | 585,995 | 2.75 |
| 2026-07-31 | 1,446,289 | -2.3% | 258,683 | 5.59 |
| 2026-07-15 | 1,479,856 | +9.0% | 328,722 | 4.50 |
| 2026-06-30 | 1,357,645 | +6.2% | 408,267 | 3.33 |
| 2026-06-15 | 1,278,246 | +7.6% | 292,250 | 4.37 |
| 2026-05-29 | 1,188,069 | +3.0% | 318,465 | 3.73 |
| 2026-05-15 | 1,153,458 | -0.8% | 309,933 | 3.72 |
| 2026-04-30 | 1,162,198 | -15.3% | 156,045 | 7.45 |
| 2026-04-15 | 1,372,456 | +2.9% | 174,005 | 7.89 |
| 2026-03-31 | 1,333,245 | +5.9% | 315,689 | 4.22 |
| 2026-03-13 | 1,259,193 | +3.0% | 217,271 | 5.80 |
| 2026-02-27 | 1,223,055 | +4.5% | 313,932 | 3.90 |
| 2026-02-13 | 1,170,798 | +1.6% | 125,705 | 9.31 |
| 2026-01-30 | 1,152,720 | -6.1% | 131,600 | 8.76 |
| 2026-01-15 | 1,227,887 | +5.7% | 154,812 | 7.93 |
| 2025-12-31 | 1,161,784 | +2.8% | 178,757 | 6.50 |
| 2025-12-15 | 1,129,732 | +4.2% | 177,204 | 6.38 |
| 2025-11-28 | 1,084,587 | -7.7% | 206,541 | 5.25 |
| 2025-11-14 | 1,175,225 | -3.4% | 182,699 | 6.43 |
| 2025-10-31 | 1,216,468 | -0.7% | 121,680 | 10.00 |
| 2025-10-15 | 1,224,447 | -0.8% | 103,202 | 11.86 |
| 2025-09-30 | 1,234,421 | -2.6% | 224,064 | 5.51 |
| 2025-09-15 | 1,267,733 | -6.0% | 144,156 | 8.79 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of LMAT volume is 68.8%, down 11.4 points over the last five sessions. Over the last 52 readings it ranged from 25.9% (14 August 2026) to 93.0% (13 July 2026). The latest reading is 2.7 points above the 30-session average of 66.1%, on 99K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 68K | 99K | 68.8% | 0 |
| 2026-09-16 | 80K | 120K | 66.8% | 0 |
| 2026-09-15 | 92K | 131K | 70.3% | 0 |
| 2026-09-14 | 51K | 78K | 64.5% | 0 |
| 2026-09-11 | 93K | 128K | 72.4% | 0 |
| 2026-09-10 | 87K | 108K | 80.2% | 2,082 |
| 2026-09-09 | 87K | 117K | 74.2% | 0 |
| 2026-09-08 | 46K | 69K | 66.4% | 96 |
| 2026-09-04 | 40K | 57K | 70.9% | 5,759 |
| 2026-09-03 | 93K | 146K | 63.9% | 0 |
| 2026-09-02 | 65K | 94K | 68.9% | 0 |
| 2026-09-01 | 87K | 109K | 80.0% | 0 |
| 2026-08-31 | 87K | 128K | 68.1% | 0 |
| 2026-08-28 | 54K | 83K | 64.2% | 0 |
| 2026-08-27 | 63K | 80K | 78.7% | 0 |
| 2026-08-26 | 29K | 49K | 59.5% | 0 |
| 2026-08-25 | 80K | 154K | 52.1% | 0 |
| 2026-08-24 | 82K | 161K | 51.0% | 0 |
| 2026-08-21 | 71K | 124K | 57.6% | 0 |
| 2026-08-20 | 94K | 110K | 85.9% | 0 |
| 2026-08-19 | 83K | 107K | 77.4% | 0 |
| 2026-08-18 | 95K | 167K | 57.0% | 0 |
| 2026-08-17 | 62K | 94K | 66.3% | 0 |
| 2026-08-14 | 76K | 295K | 25.9% | 1,946 |
| 2026-08-13 | 75K | 124K | 60.8% | 0 |
| 2026-08-12 | 88K | 111K | 79.6% | 0 |
| 2026-08-11 | 86K | 114K | 75.5% | 0 |
| 2026-08-10 | 95K | 230K | 41.3% | 0 |
| 2026-08-07 | 105K | 149K | 70.4% | 0 |
| 2026-08-06 | 183K | 282K | 65.0% | 960 |
Fails to deliver
SEC, by settlement date. JSONAs of 27 August 2026, the fails-to-deliver balance in LMAT is 55 shares, up 32 shares over the last settlement date. Over the last 52 readings it ranged from 2 shares (27 March 2026) to 14,636 shares (20 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-27 | 55 | $79.61 | $4K |
| 2026-08-26 | 23 | $78.97 | $2K |
| 2026-08-25 | 23 | $79.96 | $2K |
| 2026-08-24 | 3 | $81.86 | $246 |
| 2026-08-20 | 6 | $83.87 | $503 |
| 2026-08-17 | 2,040 | $82.38 | $168K |
| 2026-08-03 | 43 | $101.32 | $4K |
| 2026-07-31 | 184 | $102.19 | $19K |
| 2026-07-28 | 273 | $98.93 | $27K |
| 2026-07-24 | 84 | $97.49 | $8K |
| 2026-07-22 | 32 | $100.61 | $3K |
| 2026-07-20 | 14,636 | $101.63 | $1.5M |
| 2026-07-16 | 20 | $99.79 | $2K |
| 2026-07-01 | 10,875 | $95.96 | $1.0M |
| 2026-06-30 | 8,242 | $96.00 | $791K |
| 2026-06-29 | 163 | $95.66 | $16K |
| 2026-06-25 | 90 | $92.25 | $8K |
| 2026-06-23 | 108 | $88.61 | $10K |
| 2026-06-22 | 3 | $93.95 | $282 |
| 2026-06-18 | 572 | $92.21 | $53K |
| 2026-06-15 | 5 | $91.96 | $460 |
| 2026-06-03 | 849 | $91.62 | $78K |
| 2026-05-19 | 51 | $100.83 | $5K |
| 2026-05-14 | 1,751 | $98.17 | $172K |
| 2026-05-01 | 479 | $109.75 | $53K |
| 2026-04-22 | 423 | $111.90 | $47K |
| 2026-04-21 | 404 | $115.00 | $46K |
| 2026-04-15 | 1,229 | $117.39 | $144K |
| 2026-04-07 | 316 | $109.16 | $34K |
| 2026-04-06 | 96 | $108.49 | $10K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONNo open-market insider trades were reported for LMAT in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Roush John A on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Roush John A | n/a | Option exercise | 3K | $48.60 | $167K | 7K |
| 2026-06-04 | LeMaitre George W | Chairman and CEO | Grant | 12K | $0.00 | $0 | 45K |
| 2026-06-04 | LeMaitre George W | Chairman and CEO | Gift | 12K | $0.00 | $0 | 1.4M |
| 2026-05-08 | LeMaitre George W | Chairman and CEO | Sell | 28K | $108.69 | $3.0M | 1.4M |
| 2026-05-08 | Kamke Trent G | Senior V. P., Operations | Sell | 3K | $107.00 | $313K | 4K |
| 2026-05-07 | LeMaitre George W | Chairman and CEO | Sell | 19K | $107.64 | $2.0M | 1.5M |
| 2026-05-07 | Ross Bridget A | n/a | Sell | 5K | $111.10 | $560K | 4K |
| 2026-05-07 | Ross Bridget A | n/a | Option exercise | 2K | $47.19 | $76K | 9K |
| 2026-05-07 | Ross Bridget A | n/a | Option exercise | 3K | $48.60 | $167K | 7K |
| 2026-05-07 | Jasinski Lawrence J | n/a | Sell | 4K | $110.00 | $434K | 5K |
| 2026-05-07 | Jasinski Lawrence J | n/a | Option exercise | 865 | $101.12 | $87K | 9K |
| 2026-05-07 | Jasinski Lawrence J | n/a | Option exercise | 924 | $54.65 | $50K | 8K |
| 2026-05-07 | Jasinski Lawrence J | n/a | Option exercise | 1K | $47.19 | $50K | 7K |
| 2026-04-22 | Pellegrino Joseph P JR | n/a | Option exercise | 3K | $35.48 | $104K | 15K |
| 2026-03-11 | Roberts David B | President and Director | Sell | 3K | $107.68 | $357K | 15K |
| 2026-03-11 | Kamke Trent G | Senior V. P., Operations | Sell | 3K | $108.50 | $285K | 7K |
| 2026-03-11 | Kamke Trent G | Senior V. P., Operations | Option exercise | 3K | $35.48 | $93K | 9K |
| 2026-03-10 | LeBlanc Dorian Paul | Chief Financial Officer | Tax withholding | 96 | $109.20 | $10K | 2K |
| 2026-03-10 | LeBlanc Dorian Paul | Chief Financial Officer | Option exercise | 2 | $0.00 | $0 | 2K |
| 2026-03-02 | LeMaitre George W | Chairman and CEO | Sell | 56K | $107.81 | $6.0M | 1.5M |
| 2026-03-02 | LeMaitre George W | Chairman and CEO | Gift | 5K | $0.00 | $0 | 1.5M |
| 2026-02-27 | Roberts David B | President and Director | Sell | 8K | $106.80 | $904K | 18K |
| 2026-02-27 | Kamke Trent G | Senior V. P., Operations | Sell | 1K | $110.29 | $115K | 7K |
| 2026-02-26 | SHADAN MARTHA | n/a | Option exercise | 1 | $0.00 | $0 | 3K |
| 2026-02-26 | SHADAN MARTHA | n/a | Grant | 476 | $0.00 | $0 | 3K |
| 2026-02-26 | Roush John A | n/a | Option exercise | 1 | $0.00 | $0 | 4K |
| 2026-02-26 | Roush John A | n/a | Grant | 476 | $0.00 | $0 | 4K |
| 2026-02-26 | Ross Bridget A | n/a | Option exercise | 1 | $0.00 | $0 | 4K |
| 2026-02-26 | Ross Bridget A | n/a | Grant | 476 | $0.00 | $0 | 4K |
| 2026-02-26 | O'Connor John James | n/a | Option exercise | 1 | $0.00 | $0 | 63K |
| 2026-02-26 | O'Connor John James | n/a | Grant | 476 | $0.00 | $0 | 63K |
| 2026-02-26 | Pellegrino Joseph P JR | n/a | Option exercise | 4 | $0.00 | $0 | 12K |
| 2026-02-26 | Pellegrino Joseph P JR | n/a | Grant | 2K | $0.00 | $0 | 12K |
| 2026-02-26 | Roberts David B | President and Director | Tax withholding | 13 | $113.69 | $1K | 26K |
| 2026-02-26 | Roberts David B | President and Director | Tax withholding | 134 | $113.69 | $15K | 26K |
| 2026-02-26 | Roberts David B | President and Director | Option exercise | 3 | $0.00 | $0 | 27K |
| 2026-02-26 | Roberts David B | President and Director | Grant | 146 | $0.00 | $0 | 27K |
| 2026-02-26 | Roberts David B | President and Director | Grant | 2K | $0.00 | $0 | 26K |
| 2026-02-26 | LeMaitre George W | Chairman and CEO | Tax withholding | 496 | $113.69 | $56K | 1.5M |
| 2026-02-26 | LeMaitre George W | Chairman and CEO | Option exercise | 13 | $0.00 | $0 | 1.5M |
| 2026-02-26 | LeMaitre George W | Chairman and CEO | Grant | 6K | $0.00 | $0 | 1.5M |
| 2026-02-26 | LeMaitre George W | Chairman and CEO | Sell | 150K | $106.76 | $16.0M | 1.5M |
| 2026-02-26 | Kamke Trent G | Senior V. P., Operations | Tax withholding | 93 | $113.69 | $11K | 8K |
| 2026-02-26 | Kamke Trent G | Senior V. P., Operations | Option exercise | 2 | $0.00 | $0 | 8K |
| 2026-02-26 | Kamke Trent G | Senior V. P., Operations | Grant | 1K | $0.00 | $0 | 8K |
| 2026-02-26 | Jasinski Lawrence J | n/a | Option exercise | 1 | $0.00 | $0 | 6K |
| 2026-02-26 | Jasinski Lawrence J | n/a | Grant | 476 | $0.00 | $0 | 6K |
| 2026-02-05 | Roberts David B | President and Director | Option exercise | 7 | $48.60 | $340 | 25K |
| 2026-02-05 | Roberts David B | President and Director | Option exercise | 3K | $37.29 | $100K | 25K |
| 2026-01-08 | Kamke Trent G | Senior V. P., Operations | Option exercise | 1K | $48.60 | $54K | 7K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON11 Form 144 notices on file for LMAT worth $40.9M at the prices reported; 1 in the last 90 days worth $449K. Latest: BRIDGET A ROSS filed on 2026-07-29 to sell 4,322 shares ($449K) from 2026-07-29.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-07-29 | BRIDGET A ROSSDirector | 4K | $449K | 0.019% | 2026-07-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-08 | TRENT G KAMKEOfficer | 3K | $313K | 0.013% | 2026-05-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | BRIDGET A ROSSDirector | 5K | $560K | 0.022% | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | LAWRENCE J. JASINSKIDirector | 4K | $434K | 0.017% | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-11 | Roberts David BOfficer | 3K | $358K | 0.015% | 2026-03-11 | Charles Schwab Corp |
| 2026-03-11 | TRENT G KAMKEOfficer | 3K | $285K | 0.012% | 2026-03-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | LeMaitre George WOfficer | 200K | $21.4M | 0.878% | 2026-03-02 | Charles Schwab Corp. |
| 2026-02-27 | Roberts David BAffiliate | 8K | $962K | 0.037% | 2026-02-27 | Charles Schwab & Co., Inc. |
| 2026-02-27 | TRENT G KAMKEOfficer | 1K | $115K | 0.005% | 2026-02-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-26 | LeMaitre George WOfficer, Director | 50K | $5.7M | 0.220% | 2026-02-26 | THE CHARLES SCHWAB CORPORATION |
| 2026-02-26 | LeMaitre George WOfficer, Director | 100K | $10.4M | 0.439% | 2026-02-26 | THE CHARLES SCHWAB CORPORATION |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON6 holders above 5% have filed on LMAT, all on Schedule 13G (passive). The largest reported stake is Conestoga Capital Advisors at 8.1% of the class (1,527,429 shares), filed 2026-01-09 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-27 | 13G | First Trust Advisors L.P.investment adviser | 1.2M | 5.2% | 2026-06-30 |
| 2026-07-27 | 13G | The Charger Corporationparent holding company | 1.2M | 5.2% | 2026-06-30 |
| 2026-07-27 | 13G | First Trust Portfolios L.P.broker-dealer | 1.2M | 5.2% | 2026-06-30 |
| 2026-05-14 | 13G/Ano. 20 | George W. LeMaitreindividual | 1.5M | 6.4% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 6 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-01-09 | 13G/Ano. 9 | Conestoga Capital Advisorsinvestment adviser | 1.5M | 8.1% | 2025-12-31 |
| 2025-11-12 | 13G/Ano. 19 | George W. LeMaitreindividual | 1.7M | 7.4% | 2025-09-30 |
13F holders
Tracked managers holding LMAT at their latest 13F. JSON7 of the 30 tracked managers held LMAT at their latest 13F, $73.9M in total at quarter-end prices. Two Sigma Investments is the largest at $30.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 317K | $30.4M | 0.02% | +35K |
| Renaissance Technologies | 2026-06-30 | 170K | $16.3M | 0.02% | +31K |
| Citadel Advisors | 2026-06-30 | 15.3M | $16.2M | 0.00% | -4.5M |
| Citadel Advisors | 2026-06-30 | 49K | $4.7M | 0.00% | -15.2M |
| D. E. Shaw & Co. | 2026-06-30 | 36K | $3.5M | 0.00% | -47K |
| AQR Capital Management | 2026-06-30 | 21K | $2.0M | 0.00% | +221 |
| Millennium Management | 2026-06-30 | 9K | $863K | 0.00% | -45K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn FY 2025 it generated $81.3M of operating cash flow and spent $1.8M on buybacks and $18.1M on dividends.
- Cash
- $26.6M
- Equity
- $420.3M
- Total assets
- $640.5M
- Shares outstanding
- 22,869,257
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | n/a | $17.1M | n/a | 0.74 |
| Q1 2026 | 2026-03-31 | n/a | $15.7M | n/a | 0.68 |
| Q4 2025derived | 2025-12-31 | n/a | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | n/a | $17.4M | n/a | 0.75 |
| Q2 2025 | 2025-06-30 | n/a | $13.8M | n/a | 0.60 |
| Q1 2025 | 2025-03-31 | n/a | $11.0M | n/a | 0.48 |
| Q4 2024derived | 2024-12-31 | $55.7M | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $54.8M | $11.1M | 20.3% | 0.49 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $249.6M | n/a | $81.3M | n/a | $1.8M | $18.1M |
| FY 2024 | 2024-12-31 | $219.9M | n/a | $44.1M | n/a | $1.7M | $14.4M |
| FY 2023 | 2023-12-31 | $193.5M | n/a | $36.8M | n/a | $853K | $12.4M |
| FY 2022 | 2022-12-31 | $161.7M | n/a | $25.4M | n/a | $642K | $11.0M |
| FY 2021 | 2021-12-31 | $154.4M | n/a | $35.1M | n/a | $802K | $9.3M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-02 from the cover page.
What this page is
LEMAITRE VASCULAR INC in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows LEMAITRE VASCULAR INC (LMAT), SEC CIK 1158895, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-27.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-07-29.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-07-27.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-04.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1158895Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- BSXBOSTON SCIENTIFIC CORP
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- SIBNSI-BONE, Inc.
- MMM3M CO
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- RMDRESMED INC
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ICUIICU MEDICAL INC/DE
- ATECAlphatec Holdings, Inc.
- AORTARTIVION, INC.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- ANGOANGIODYNAMICS INC
- OFIXOrthofix Medical Inc.
Datasets
Frequently Asked Questions
How much of LMAT is sold short?
What is LMAT's daily short volume?
Does LMAT have fails to deliver?
Are LMAT insiders buying or selling?
Have LMAT insiders filed to sell?
Who owns more than 5% of LMAT?
What did LMAT report last quarter?
Which funds hold LMAT?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.